Ekso Bionics Holdings (EKSO) Depreciation and Depletion (2016 - 2023)
Ekso Bionics Holdings has reported Depreciation and Depletion over the past 11 years, most recently at $414000.0 for Q1 2023.
- On a quarterly basis, Depreciation and Depletion rose 79.22% to $414000.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $669000.0, a 0.45% change, with the full-year FY2025 number at $563000.0, down 14.44% from a year prior.
- Depreciation and Depletion reached $414000.0 in Q1 2023 per EKSO's latest filing, up from -$146000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $414000.0 in Q1 2023, with the low at -$221000.0 in Q4 2021.
- The 5-year median for Depreciation and Depletion is $170000.0 (2022), against an average of $163000.0.
- Peak YoY movement for Depreciation and Depletion: soared 457.69% in 2020, then plummeted 242.58% in 2021.
- Tracing EKSO's Depreciation and Depletion over 5 years: stood at $171000.0 in 2019, then decreased by 9.36% to $155000.0 in 2020, then plummeted by 242.58% to -$221000.0 in 2021, then soared by 33.94% to -$146000.0 in 2022, then soared by 383.56% to $414000.0 in 2023.
- According to Business Quant data, Depreciation and Depletion over the past three periods came in at $414000.0, -$146000.0, and $170000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.